Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2026-03-02 @ 4:23 PM
Study NCT ID:
NCT01490632
Status:
COMPLETED
Last Update Posted:
2019-09-27
First Post:
2011-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-09
First Submit QC Date:
None
Study First Post Date:
2011-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-10
Results First Submit QC Date:
None
Results First Post Date:
2017-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-01-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-09-10
Last Update Post Date:
2019-09-27
Last Update Post Date Type:
ACTUAL